Indian drug exports up 27.9% at interim

9 January 2001

Pharmaceutical exports from India grew a record 27.9% duringApril-September 2000 to reach a value of 82.8 billion rupees ($2.5 million), indicating that the 171.5 billion-rupee full-year export target set by the government for the sector will be met, according to an official statement reported by the India Infoline news service.

Full-year exports for the previous year reached a value of 138.2 billion rupees, it says, adding that the Indian manufacturing industry is now able to meet 70% of national demand for bulk drugs and almost the total domestic requirement for formulations. The release also says the cost of bulk drug production in India is 60% lower than in most developed countries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight